InsiderFlow

Mark Hopman

BBNX

Mark Hopman serves as officer: Chief Commercial Officer at Beta Bionics, Inc. (BBNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

6 trades

$695.4K

Net Position

Net Seller

$695.4K

Companies Traded

1

BBNX

Active Period

Jun 2025 – Mar 2026

6 total trades

Most Recent

Sell BBNX

Mar 5, 2026 · $4.1K

Mark Hopman's Insider Trading at Beta Bionics, Inc. (BBNX)

Buys

0 · $0.00

Sells

6 · $695.4K

Total Shares Bought

0

Total Shares Sold

38,124

BBNX Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Mar 5, 2026↗Sell353$11.57$4.1K139,133
Mar 3, 2026↗Sell1,668$12.36$20.6K139,486
Sep 4, 2025↗Sell18,229$20.34$370.8K0
Sep 2, 2025↗Sell848$18.86$16.0K0
Aug 19, 2025↗Sell16,158$16.61$268.4K0
Jun 2, 2025↗Sell868$17.89$15.5K0

Related Insiders

Steven Jon Russell

officer: Chief Medical Officer

BBNXSell · Mar 2, 2026

Stephen Feider

officer: Chief Financial Officer

BBNXSell · Mar 2, 2026

Mike Mensinger

officer: Chief Product Officer

BBNXSell · Mar 2, 2026

Sean Saint

director, officer: President & CEO

BBNXSell · Mar 2, 2026

Mike Mensinger

Chief Product Officer

BBNXSell · Jan 6, 2026

Stephen Feider

Chief Financial Officer

BBNXSell · Jan 2, 2026

Sean Saint

President & CEO

BBNXSell · Dec 2, 2025

Maria Palasis

Director

BBNXSell · Dec 1, 2025

Explore More Insider Trading Data

BBNX Insider Trading Activity

View all insider trades at Beta Bionics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity

Mark Hopman Insider Trading Activity | Beta Bionics, Inc. | InsiderFlow